VOLUME

Chaisathaphol T, Chayakulkeeree M. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital. J Med Assoc Thai 2014;97(Suppl 3):S35-45.

Inchai J, Pothirat C, Liwsrisakun C, et al. Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality. Jpn J Infect Dis 2015;68(3):181-6.

Werarak P, Waiwarawut J, Tharavichitkul P, et al. Acinetobacter baumannii nosocomial pneumonia in tertiary care hospitals in Thailand. J Med Assoc Thai 2012;95(Suppl 2):S23-33.

Santimaleeworagun W, Wongpoowarak P, Chayakul P, et al. Clinical outcomes of patients infected with carbapenem- resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. J Med Assoc Thai 2011;94(7):863-70.

National antimicrobial resistant service center, Thailand (NARST). Percentage of susceptible organisms isolated from all specimen, 74 hospitals, Jan - Dec 2017. (Accessed June 3, 2018, at http://narst.dmsc.moph.go.th/antibiograms/2017/12/ Jan-Dec2017-All.pdf).

Lemos EV, de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect 2014;20(5):416-23.

Aydemir H, Akduman D, Piskin N, et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator- associated pneumonia. Epidemiol Infect 2013;141(6):1214-22.

Li J, Yang X, Chen L, et al. In Vitro activity of various antibiotics in combination with tigecycline against Acinetobacter baumannii: A systematic review and meta-analysis. Microb Drug Resist 2017;23(8):982-93.

Ni W, Shao X, Di X, et al. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis. Int J Antimicrob Agents 2015;45(1):8-18.

Tigecycline. In: In Depth Answers [database on the Internet]. Greenwood Village (CO): Truven Health Analytics; 2018. (Accessed June 20, 2018, at www.micromedexsolutions.com. Subscription required to view.).

Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother 2007;41(6):965-72.

Gotfried MH, Horn K, Garrity-Ryan L, et al. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects. Antimicrob Agents Chemother 2017;61(9): e01135-17.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, et al. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia. Int J Antimicrob Agents 2014;43(4):378-82.

Papst L, Beovic B, Pulcini C, et al. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect 2018;pii:S1198- 743X(18)30069-7.

Karaoglan I, Zer Y, Bosnak VK, et al. In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. J Int Med Res 2013;41(6):1830-7.

Kaya IA, Guner MD, Akca G, et al. Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii. Pak J Med Sci 2017;33(2):393-7.

Cikman A, Gulhan B, Aydin M, et al. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem- Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia. Int J Med Sci 2015;12(9):695-700.

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 28th ed. Wayne: Clinical and Laboratory Standards Institute; 2018.

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 8.1 [online]. 2018. (Accessed April 10, 2018, at http://www.eucast.org/clinical_breakpoints/.)

Conte JE Jr, Golden JA, Kelly MG, et al. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline. Int J Antimicrob Agents 2005;25(6):523-9.

Arthur LE, Kizor RS, Selim AG, et al. Antibiotics for ventilator-associated pneumonia. Cochrane Database Syst Rev 2016;10:CD004267.

Chuang YC, Cheng CY, Sheng WH, et al. Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis. BMC Infect Dis 2014;14:102.

Cheng A, Chuang YC, Sun HY, et al. Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii Bacteremia: A multicenter prospective observational study. Crit Care Med 2015;43(6):1194-204.